The White House confirmed that Scott Gottlieb will be nominated as the next commissioner of the FDA.

Gottlieb, who served as the FDA’s deputy commissioner for medical and scientific affairs from 2005 to 2007, is currently a resident fellow at the American Enterprise Institute, and advises HHS as a member of the Federal Health IT Policy Committee. He has served on boards at GlaxoSmithKline and Daiichi Sankyo.

His nomination must be confirmed by the Senate Health, Education, Labor and Pensions Committee, and the Senate.